Arvinas (ARVN) FCF Margin Growth (3y) (2020 - 2026)
Powered by 
Analysis
Arvinas (ARVN) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -3,088.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 14,060.00 |
| 10 | Arvinas | 609.77 Mn | 41.87 Mn | - | 14,443.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14,443.00 |
| Mar 31, 2026 | -16,792.00 |
| Dec 31, 2025 | -13,084.00 |
| Sep 30, 2025 | 6,594.00 |
| Jun 30, 2025 | -19,456.00 |
| Mar 31, 2025 | 17,610.00 |
| Dec 31, 2024 | -2,931.00 |
| Sep 30, 2024 | -743,966.00 |
| Jun 30, 2024 | 93,575.00 |
| Mar 31, 2024 | 34,150.00 |
| Dec 31, 2023 | 68,024.00 |
| Sep 30, 2023 | 6,490.00 |
| Jun 30, 2023 | 24,024.00 |
| Mar 31, 2023 | 948.00 |
| Dec 31, 2022 | 17,652.00 |
| Sep 30, 2022 | -20,944.00 |
| Jun 30, 2022 | 16,980.00 |
| Mar 31, 2022 | 10,630.00 |
| Dec 31, 2021 | 26,102.00 |
| Sep 30, 2021 | 766,731.00 |